ADIPOQ and Obesity: In fact, adiponectin has been previously shown to be downregulated in patients with obesity [20] and a low adiponectin to leptin (Adpn/Lep) ratio suggests an increased cardiometabolic risk, systemic inflammation and oxidative stress [19].